Biliary stents market seen rising to $0.66 billion by 2030

The Business Research Company projects the biliary stents market will grow from $0.53 billion in 2026 to $0.66 billion by 2030, driven by more pancreatic cancer cases, broader use of minimally invasive procedures and newer stent technologies. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Biliary stents are used to keep bile ducts open and reduce blockages that can cause jaundice and liver damage. - Market growth signals rising demand for procedures that treat bile duct obstruction and support cancer care. - The forecast points to more use of newer devices that may improve patient outcomes and expand treatment options.

What happened: - The Business Research Company released a biliary stents market report covering market size, trends and forecasts through 2035. - The market is projected to rise from $0.5 billion in 2025 to $0.53 billion in 2026. - The market is expected to reach $0.66 billion by 2030. - The report says the 2026-2030 period implies a 5.6% CAGR. - A free sample of the report is available here. - The full report is available here.

The details: - Historical growth was supported by a narrow range of stent materials, heavy use of traditional plastic stents, rising biliary obstruction cases, more hospital-based procedures and limited access to advanced endoscopic tools. - Growth through 2030 is expected to be supported by covered and partially covered metal stents, biodegradable polymer stents, minimally invasive surgery, better awareness of stent-related complications, imaging techniques and smart stent technologies. - Key trends include wider use of self-expandable metal stents, more biodegradable polymer stents, growth in endoscopic and minimally invasive treatments, broader applications in pancreatic and gallstone therapies, and more focus on patient safety and outcomes. - Biliary stents are slender tube-shaped devices placed inside bile ducts to keep them open and allow bile to flow from the liver to the intestines. - The devices are used to relieve blockages caused by tumors, gallstones, inflammation and other medical issues. - Biliary stents help reduce symptoms such as jaundice and lower the risk of liver damage. - The report says rising pancreatic cancer incidence is a major growth driver. - Pancreatic cancer is linked to aging populations and higher rates of obesity, diabetes and smoking. - Cancer Australia reported 4,641 new pancreatic cancer cases in 2024, including 2,414 males and 2,227 females. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook suggests a shift from standard plastic stents toward more specialized metal and biodegradable products. - The emphasis on smart stents and imaging points to a broader move toward more precise and less invasive care. - Cancer-related use cases remain central to demand, but the report also points to wider gastrointestinal applications.

What's next: - The market is expected to keep expanding as minimally invasive procedures become more common. - Adoption of newer stent designs should shape competitive positioning through the rest of the decade. - Regional growth will likely stay strongest in Asia-Pacific as broader healthcare access and procedure volumes expand. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis. - The company also provided contact details for its expert team and social channels.